60 Degrees Pharmaceuticals, Inc. Share Price

60 Degrees Pharmaceuticals, Inc. Share Price

NASDAQ: SXTP | Micro Cap
$0.97
+$0.14 (16.21%) Last updated on 30 Oct, 2026 | 01:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

60 Degrees Pharmaceuticals, Inc. Stock Performance

Open
$0.86
Prev. Close
$0.83
Circuit Range
N/A
Day Range
$0.86 - $0.92
Year Range
$0.40 - $8.22
Volume
3,749
Average Traded
$0.91

60 Degrees Pharmaceuticals, Inc. Share Price Today

As of 30 October 2026, 60 Degrees Pharmaceuticals, Inc.'s share price is $0.97. The stock opened at $0.86, compared to its previous close of $0.83. During today's trading session, 60 Degrees Pharmaceuticals, Inc.'s share price traded between $0.86 and $0.92, with an average price of $0.89. Over the past 52 weeks, the stock has recorded a high of $8.22 and a low of $0.40. In terms of performance, 60 Degrees Pharmaceuticals, Inc.'s share price has declined by 38.81% over the last six months and is down 28.68% on a year-on-year basis.

60 Degrees Pharmaceuticals, Inc. Share Price Chart

Line chart of the 60 Degrees Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 0.86 to 0.97, ending at 0.97.
$0.86$0.92
L
Show Current Price
H

60 Degrees Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$440899.08
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.45
Revenue (TTM)
$1.41B
Return On Equity (TTM)
-329.59%
Profit Margin
-557.45%
Debt to Equity
0.06
Quarterly Earnings Growth YoY
1.64%

60 Degrees Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.53$0.32$0.16$0.21
Net Profit-$2.44-$1.57-$2.21-$2.40
Net Profit Margin-460.38%-490.63%-1381.25%-1142.86%
Income ChangeN/A35.66%-40.76%-8.60%

60 Degrees Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.25$0.68$1.41
Net Profit-$3.92-$8.43-$7.86
Net Profit Margin-1568.00%-1239.71%-557.45%
Income ChangeN/A-115.05%6.76%

About 60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

60 Degrees Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.28
$0.92
-23.58%
Sep 2026
$1.06
$1.20
+12.68%
Aug 2026
$1.14
$1.06
-4.48%
Jul 2026
$1.87
$1.11
-30.75%
Jun 2026
$1.49
$1.61
+7.69%
May 2026
$1.67
$1.50
-5.68%
Apr 2026
$1.74
$1.58
-8.65%
Mar 2026
$2.72
$1.74
-40.38%
Feb 2026
$3.62
$2.91
-31.37%
Jan 2026
$0.52
$4.24
+733.01%
Dec 2025
$1.09
$0.51
-48.59%
Nov 2025
$1.32
$0.99
-27.21%

SXTP Share Price FAQs